Statistical Joint Modeling for Predicting the Association of CD4 Measurement and Time to Death of People Living with HIV Who Enrolled in ART, Southwest Ethiopia

References

• World Health Organization. HIV/AIDS [Internet]. Genva; 2020. [cited September 20, 2020]. Available from https://www.who.int/health-topics/hiv-aids/#tab=tab_1. Accessed December 31, 2020.
   Google Scholar
• World Health Organization Geneva. HIV/AIDS fact sheet [internet]. 2020 [cited September 20, 2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed December 31, 2020.
   Google Scholar
• World Health Organization. HIV Country Profiles [Internet]. Geneva; 2020 [cited September 20, 2020]. Available from: https://cfs.hivci.org/country-factsheet.html. Accessed December 31, 2020.
   Google Scholar
• Trickey A, May MT, Vehreschild JJ, et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–e356. doi:10.1016/S2352-3018(17)30066-8
   PubMed Web of Science ®Google Scholar
• Fontela C, Aguinaga A, Moreno-Iribas C, et al. Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population. Sci Rep. 2020;10(1):1–9. doi:10.1038/s41598-020-65841-0
   PubMed Web of Science ®Google Scholar
• May MT, Vehreschild -J-J, Trickey A, et al. Mortality according to CD4 count at start of combination antiretroviral therapy among HIV-infected Patients followed for up to 15 years after start of treatment: collaborative Cohort Study. Clin Infect Dis. 2016;62(12):1571–1577. doi:10.1093/cid/ciw183
   PubMed Web of Science ®Google Scholar
• Tang Z, Pan SW, Ruan Y, et al. Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study. Sci Rep. 2017;7(1):1–8. doi:10.1038/s41598-016-0028-x
   PubMed Web of Science ®Google Scholar
• Cardoso CAA, Pinto JA, Candiani TMS, de Carvalho IR, Linhares RM, Goulart EMA. The impact of highly active antiretroviral therapy on the survival of vertically HIV-infected children and adolescents in Belo Horizonte, Brazil. Mem Inst Oswaldo Cruz. 2012;107(4):532–538. doi:10.1590/S0074-02762012000400014
   Web of Science ®Google Scholar
• Edmonds A, Yotebieng M, Lusiama J, et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a Cohort Study. Bangsberg DR, editor. PLoS Med. 2011;8(6):e1001044. doi:10.1371/journal.pmed.1001044
   PubMed Web of Science ®Google Scholar
• Lv R, Li G, Wu J, Zhu Y, Qin X, Li S. Research on AIDS patients’ survival time after highly active antiretroviral therapy, treatment effect and treatment modes. Saudi Pharm J. 2016;24(3):318–321. doi:10.1016/j.jsps.2016.04.004
   Web of Science ®Google Scholar
• WHO. What’s new in treatment monitoring: viral load and CD4 testing [Internet]. [cited September 20, 2020]. Available from https://www.who.int/hiv/pub/arv/treatment-monitoring-info-2017/en/. Accessed December 31, 2020.
   Google Scholar
• Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(6):363–370. doi:10.1016/j.trstmh.2012.03.002
   Web of Science ®Google Scholar
• Abebe N, Alemu K, Asfaw T, Abajobir AA. Survival status of HIV positive adults on antiretroviral treatment in Debre markos referral hospital, Northwest Ethiopia: retrospective cohort study. Pan Afr Med J. 2014;17:1937–8688. doi:10.11604/pamj.2014.17.88.3262
   Google Scholar
• Jerene D, Næss A, Lindtjørn B. Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther. 2006;3(1):1–8. doi:10.1186/1742-6405-3-10
   Google Scholar
• Asar Ö, Ritchie J, Kalra PA, Diggle PJ. Joint modelling of repeated measurement and time-to-event data: an introductory tutorial. Int J Epidemiol. 2015;44(1):334–344. doi:10.1093/ije/dyu262
   PubMed Web of Science ®Google Scholar
• Fewell Z, Hernán MA, Wolfe F, Tilling K, Choi H, Sterne JAC. Controlling for time-dependent confounding using marginal structural models. Stata J. 2004;4(4):402–420. doi:10.1177/1536867X0400400403
   Web of Science ®Google Scholar
• Ibrahim JG, Chu H, Chen LM. Basic concepts and methods for joint models of longitudinal and survival data [internet]. J Clin Oncol. 2010;28(16):2796–2801. doi:10.1200/JCO.2009.25.0654
   PubMed Web of Science ®Google Scholar
• Guo X, Carlin BP. Separate and joint modelling of longitudinal and event time data using standard computer packages. Am Stat. 2004;58(1):1. doi:10.1198/0003130042854
   Web of Science ®Google Scholar
• Chen M-H, Ibrahim JG, Sinha D. A new joint model for longitudinal and survival data with a cure fraction. J Multivar Anal. 2004;91(1):18–34. doi:10.1016/j.jmva.2004.04.005
   Web of Science ®Google Scholar
• Henderson R. Joint modelling of longitudinal measurements and event time data. Biostatistics. 2000;1(4):465–480. doi:10.1093/biostatistics/1.4.465
   PubMedGoogle Scholar
• Lin H, McCulloch CE, Turnbull BW, Slate EH, Clark LC. A latent class mixed model for analysing biomarker trajectories with irregularly scheduled observations. Stat Med. 2000;19(10):1303–1318. doi:10.1002/(SICI)1097-0258(20000530)19:10<1303::AID-SIM424>3.0.CO;2-E
   Web of Science ®Google Scholar
• Liu Y, Liu L, Zhou J. Joint latent class model of survival and longitudinal data: an application to CPCRA study. Comput Stat Data Anal. 2015;91:40–50. doi:10.1016/j.csda.2015.05.007
   Web of Science ®Google Scholar
• Proust-Lima C, Séne M, Taylor JMG, Jacqmin-Gadda H. Joint latent class models for longitudinal and time-to-event data: a review. Stat Methods Med Res. 2014;23:74–90. doi:10.1177/0962280212445839
   PubMed Web of Science ®Google Scholar
• Khorashadizadeh F, Tabesh H, Parsaeian M, Esmaily H, Rahimi Foroushani A. Predicting the survival of AIDS patients using two frameworks of statistical joint modeling and comparing their predictive accuracy. Iran J Public Health. 2020;49(5):949–958.
   Web of Science ®Google Scholar
• Modelling progression of CD4-lymphocyte count and its relationship to survival time - PubMed [internet]. [cited September 25, 2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/7786983/. Accessed December 31, 2020.
   Google Scholar
• Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther. 2012;9(1):1–7. doi:10.1186/1742-6405-9-15
   PubMed Web of Science ®Google Scholar
• Ayalew MB. Mortality and Its predictors among HIV infected patients taking antiretroviral treatment in Ethiopia: a systematic review. AIDS Res Treat. 2017; 2017.
   Web of Science ®Google Scholar
• Alemu AW, Sebastián MS. Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob Health Action. 2010;3(1):5398. doi:10.3402/gha.v3i0.5398
   PubMed Web of Science ®Google Scholar
• Tachbele E, Ameni G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health. 2016;38:e2016049. doi:10.4178/epih.e2016049
   Google Scholar